Hong Kong Auto Components Stock News

Greentown China Holdings (SEHK:3900) has released unaudited sales figures for June and the first half of 2026, giving investors fresh detail on contracted volumes, pricing and project management activity. See our latest analysis for Greentown China Holdings. Following these June sales figures, Greentown China Holdings’ share price has softened, with a 30 day share price return of 18.68% and a 1 year total shareholder return decline of 33.04%, suggesting recent momentum has been weak despite...

CK Asset Holdings (SEHK:1113) has tendered a 2,137 square foot, four bedroom unit in phase 2 of its 21 Borrett Road project for over HK$157 million, highlighting fresh activity in its Hong Kong luxury portfolio. See our latest analysis for CK Asset Holdings. CK Asset Holdings' latest luxury sale comes as the stock trades at HK$45.46, with a 7 day share price return of 2.66% and a year to date share price return of 12.8%. The 1 year total shareholder return of 35.19% suggests momentum has been...

China Tobacco International (HK) Company Limited announced that, effective July 2, 2026, chairman and non-executive director Mr. Shao Yan retired, leaving vacancies across key board and committee roles and temporarily putting the company out of full compliance with Hong Kong listing rules. Beyond the leadership change itself, the immediate gaps in the nomination and remuneration committees highlight how even planned retirements can ripple through corporate governance structures. We’ll now...

While Dongyue Group Limited ( HKG:189 ) might not have the largest market cap around , it saw a significant share price...

While C.banner International Holdings Limited ( HKG:1028 ) shareholders have enjoyed a good week with stock up 12...

Zhongshen Jianye Holding Limited ( HKG:2503 ) shareholders (or potential shareholders) will be happy to see that the...

InnoCare Pharma (SEHK:9969) is back in focus after new clinical data showed its BTK inhibitor orelabrutinib was well tolerated and clinically effective in a large Phase IIb study for systemic lupus erythematosus. See our latest analysis for InnoCare Pharma. Alongside the positive lupus data, InnoCare Pharma has also started dosing patients in China with its CDH17 targeted ADC ICP-B208. The stock’s recent momentum reflects this, with a 1 month share price return of 34.55% but a 1 year total...

Man Wah Holdings (SEHK:1999) is back on investors’ radar after its recent AGM, which approved a final dividend of HK$0.09 per share and confirmed the appointment of independent non executive director Mr. Chan Hak Kan. See our latest analysis for Man Wah Holdings. Despite the AGM outcomes on dividends and board composition, Man Wah Holdings’ recent 1 day share price return of 1.68% stands against a share price that has fallen 34.7% year to date and a 5 year total shareholder return decline of...

Bloks Group (SEHK:325) drew fresh attention after its shares rose 1.75% in the latest session, leaving the stock up 4.92% over the past week but lower over the past month. See our latest analysis for Bloks Group. Looking beyond this week, Bloks Group’s share price return is down 21.57% over the past 90 days and down 26.15% year to date, while the 1 year total shareholder return has fallen 64.22%. This suggests that recent momentum is building from a weak longer term base. If Bloks Group’s...

Dividend approval puts upcoming dates in focus for CSC Financial CSC Financial (SEHK:6066) has drawn fresh attention after approving a final dividend of CN¥1.75 per 10 shares for 2025, with ex dividend on 2 July 2026 and payment scheduled for 20 August 2026. See our latest analysis for CSC Financial. The dividend decision comes after a period where CSC Financial's share price return has been mixed in the short term, with a 10.44% 90 day share price return alongside a decline of 6.55% year to...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

In recent days, Sino Biopharmaceutical announced that its subsidiary Beijing Tide had an NDA for a world-first long-acting ropivacaine hydrochloride sustained-release solution for postoperative analgesia accepted by China’s Center for Drug Evaluation, while another subsidiary granted AstraZeneca exclusive ex-China rights to the inhaled respiratory drug TQC3721 and expanded a respiratory medicines partnership with GSK in mainland China. The AstraZeneca licence, which includes a US$200 million...

Linmon Media Limited ( HKG:9857 ), is not the largest company out there, but it led the SEHK gainers with a relatively...

Sunac Services Holdings Limited ( HKG:1516 ), might not be a large cap stock, but it saw a decent share price growth of...

NIU Holdings Limited's (HKG:8619) stock price has dropped 13% in the previous week, but insiders who sold HK$963k in...

We wouldn't blame WuXi XDC Cayman Inc. ( HKG:2268 ) shareholders if they were a little worried about the fact that...

Potential Natural Food International Holding Limited ( HKG:1837 ) shareholders may wish to note that the CEO...

We wouldn't blame Tongcheng Travel Holdings Limited ( HKG:780 ) shareholders if they were a little worried about the...

The subdued stock price reaction suggests that Taste Gourmet Group Limited's ( HKG:8371 ) strong earnings didn't offer...

Those following along with Meitu, Inc. ( HKG:1357 ) will no doubt be intrigued by the recent purchase of shares by...

As Asian markets navigate a landscape marked by mixed performances and economic resilience, investors are increasingly turning their attention to dividend stocks as a source of steady income amidst global uncertainties. In this context, identifying stocks that offer strong dividend yields can be particularly appealing, especially when they align with robust financial health and stable market conditions.

The stock was sluggish on the back of Kwong Man Kee Group Limited's ( HKG:8023 ) recent earnings report. Along with the...

The stock was sluggish on the back of Sam Woo Construction Group Limited's ( HKG:3822 ) recent earnings report. We have...

As of early July 2026, Asian markets are navigating a complex landscape marked by mixed economic signals and sector-specific shifts. Investing in penny stocks—though the term might seem outdated—remains a relevant strategy for those looking to uncover growth opportunities, especially in smaller or newer companies that demonstrate strong financial health. This article highlights three such penny stocks that combine robust balance sheets with potential for significant returns, offering...